Literature DB >> 32919818

Association between ultrasound quadriceps muscle status with premorbid functional status and 60-day mortality in mechanically ventilated critically ill patient: A single-center prospective observational study.

Zheng-Yii Lee1, Su Ping Ong1, Ching Choe Ng1, Cindy Sing Ling Yap1, Julia Patrick Engkasan2, Mohd Yusof Barakatun-Nisak3, Daren K Heyland4, M Shahnaz Hasan5.   

Abstract

BACKGROUND & AIMS: In critically ill patients, direct measurement of skeletal muscle using bedside ultrasound (US) may identify a patient population that might benefit more from optimal nutrition practices. When US is not available, survey measures of nutrition risk and functional status that are associated with muscle status may be used to identify patients with low muscularity. This study aims to determine the association between baseline and changing ultrasound quadriceps muscle status with premorbid functional status and 60-day mortality.
METHODS: This single-center prospective observational study was conducted in a general ICU. Mechanically ventilated critically ill adult patients (age ≥18 years) without pre-existing systemic neuromuscular diseases and expected to stay for ≥96 h in the ICU were included. US measurements were performed within 48 h of ICU admission (baseline), at day 7, day 14 of ICU stay and at ICU discharge (if stay >14 days). Quadriceps muscle layer thickness (QMLT), rectus femoris cross sectional area (RFCSA), vastus intermedius pennation angle (PA) and fascicle length (FL), and rectus femoris echogenicity (mean and standard deviation [SD]) were measured. Patients' next-of-kin were interviewed by using established questionnaires for their pre-hospitalization nutritional risk (nutrition risk screening-2002) and functional status (SARC-F, clinical frailty scale [CFS], Katz activities of daily living [ADL] and Lawton Instrumental ADL).
RESULTS: Ninety patients were recruited. A total of 86, 53, 24 and 10 US measures were analyzed, which were performed at a median of 1, 7, 14 and 22 days from ICU admission, respectively. QMLT, RFCSA and PA reduced significantly over time. The overall trend of change of FL was not significant. The only independent predictor of 60-day mortality was the change of QMLT from baseline to day 7 (adjusted odds ratio 0.95 for every 1% less QMLT loss, 95% confidence interval 0.91-0.99; p = 0.02). Baseline measures of high nutrition risk (modified nutrition risk in critically ill ≥5), sarcopenia (SARC-F ≥4) and frailty (CFS ≥5) were associated with lower baseline QMLT, RFCSA and PA and higher 60-day mortality.
CONCLUSIONS: Every 1% loss of QMLT over the first week of critical illness was associated with 5% higher odds of 60-day mortality. SARC-F, CFS and mNUTRIC are associated with quadriceps muscle status and 60-day mortality and may serve as a potential simple and indirect measures of premorbid muscle status at ICU admission.
Copyright © 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Critical illness; Functional status; Muscle architecture; Muscle thickness; Nutrition risk; Ultrasound

Year:  2020        PMID: 32919818     DOI: 10.1016/j.clnu.2020.08.022

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  8 in total

Review 1.  Human skeletal muscle size with ultrasound imaging: a comprehensive review.

Authors:  Masatoshi Naruse; Scott Trappe; Todd A Trappe
Journal:  J Appl Physiol (1985)       Date:  2022-03-31

2.  Muscle Evaluation and Hospital-Associated Disability in Acute Hospitalized Older Adults.

Authors:  M Nagae; H Umegaki; A Yoshiko; K Fujita; H Komiya; K Watanabe; Y Yamada; T Sakai
Journal:  J Nutr Health Aging       Date:  2022       Impact factor: 5.285

3.  The Usefulness of Radiomics Methodology for Developing Descriptive and Prognostic Image-Based Phenotyping in the Aging Population: Results From a Small Feasibility Study.

Authors:  Rebeca Mirón Mombiela; Consuelo Borrás
Journal:  Front Aging       Date:  2022-04-28

Review 4.  [Assessment and technical monitoring of nutritional status of patients in intensive and intermediate care units : Position paper of the Section Metabolism and Nutrition of the German Interdisciplinary Association for Intensive and Emergency Medicine (DIVI)].

Authors:  Arved Weimann; Wolfgang H Hartl; Michael Adolph; Matthias Angstwurm; Frank M Brunkhorst; Andreas Edel; Geraldine de Heer; Thomas W Felbinger; Christiane Goeters; Aileen Hill; K Georg Kreymann; Konstantin Mayer; Johann Ockenga; Sirak Petros; Andreas Rümelin; Stefan J Schaller; Andrea Schneider; Christian Stoppe; Gunnar Elke
Journal:  Med Klin Intensivmed Notfmed       Date:  2022-04-28       Impact factor: 1.552

Review 5.  Urinary Titin N-Fragment as a Biomarker of Muscle Atrophy, Intensive Care Unit-Acquired Weakness, and Possible Application for Post-Intensive Care Syndrome.

Authors:  Nobuto Nakanishi; Rie Tsutsumi; Kanako Hara; Masafumi Matsuo; Hiroshi Sakaue; Jun Oto
Journal:  J Clin Med       Date:  2021-02-06       Impact factor: 4.241

Review 6.  The current use of ultrasound to measure skeletal muscle and its ability to predict clinical outcomes: a systematic review.

Authors:  Patrick Casey; Mohamed Alasmar; John McLaughlin; Yeng Ang; Jamie McPhee; Priam Heire; Javed Sultan
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-07-19       Impact factor: 12.063

7.  Sarcopenia as a predictor of mortality among the critically ill in an intensive care unit: a systematic review and meta-analysis.

Authors:  Xiao-Ming Zhang; Denghong Chen; Xiao-Hua Xie; Jun-E Zhang; Yingchun Zeng; Andy Sk Cheng
Journal:  BMC Geriatr       Date:  2021-06-02       Impact factor: 3.921

8.  The effect of higher versus lower protein delivery in critically ill patients: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Zheng-Yii Lee; Cindy Sing Ling Yap; M Shahnaz Hasan; Julia Patrick Engkasan; Mohd Yusof Barakatun-Nisak; Andrew G Day; Jayshil J Patel; Daren K Heyland
Journal:  Crit Care       Date:  2021-07-23       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.